Fennec Pharmaceuticals (FENC) Invested Capital (2021 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Invested Capital came in at $18.2 million in Q3 2025, down 39.31% YoY from $30.0 million in Q3 2024, and little changed on a QoQ basis from $18.2 million in Q2 2025.
Fennec Pharmaceuticals (FENC) Invested Capital (2021 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Invested Capital data on file, last reported at $18.2 million in Q3 2025.
- Quarterly Invested Capital fell 39.31% year-over-year to $18.2 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $54.6 million (down 49.52% YoY) and the FY2024 annual result came in at $18.2 million, down 39.31% from the prior year.
- Invested Capital steadied at $18.2 million in Q3 2025, from $18.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $30.0 million in Q4 2023 to a low of $500000.0 in Q1 2022.
- A 5-year average of $18.2 million and a median of $18.2 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital slumped 80.0% — and 2023, when it jumped 4900.0%.
- Tracing FENC's Invested Capital over 5 years: stood at $5.0 million in 2021, then soared by 400.0% to $25.0 million in 2022, then rose by 20.0% to $30.0 million in 2023, then sank by 39.31% to $18.2 million in 2024, then changed by 0.0% to $18.2 million in 2025.
- The last three Invested Capital figures came in at $18.2 million (Q3 2025), $18.2 million (Q2 2025), and $18.2 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.21 Mn |
| Mar 31, 2025 | 18.21 Mn |
| Dec 31, 2024 | 18.21 Mn |
| Sep 30, 2024 | 30.00 Mn |
| Jun 30, 2024 | 30.00 Mn |
| Mar 31, 2024 | 30.00 Mn |
| Dec 31, 2023 | 30.00 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 25.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.00 Mn |